Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Dermatol Pract Concept ; 14(1)2024 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-38364385

RESUMO

INTRODUCTION: Xeroderma pigmentosum (XP), a rare inherited condition, hallmarked by extreme sensitivity to sun exposure resulting in multiple skin cancers and non-malignant skin alterations is attributed to homozygous inactivating pathogenic variants (PVs) in DNA repair genes, predominantly the XPC gene. OBJECTIVES: Report a unique phenotypic expression of mutant XPC allele that may be compatible with a putative modifier role for MC1R polymorphism. METHODS: A family of 13 siblings, seven of whom were diagnosed with at least one cutaneous melanoma (N = 53) and non-melanoma skin cancers (N = 9) was studied. Of seven melanoma-affected cases, five consented for genetic analysis. CDKN2A revealed no PV in any case and subsequent whole-exome sequencing (WES) identified a rare homozygous missense PV (c.919C>T; p.Arg307Trp) in exon 8 of the XPC gene in all affected individuals. Notably, XPC PV carriers who co-harbored the p.I155T MC1R variant (N = 3) exhibited larger number of tumors, deeper Breslow indexes, higher rates of invasive melanomas and earlier age at diagnosis compared with non MC1R variant carriers (N = 2). CONCLUSIONS: Familial malignant melanoma phenotype may, in fact, be an unusual clinical presentation of XPC, and MC1R may be a genetic modifier of penetrance and phenotype of mutant XPC alleles.

2.
Artigo em Inglês | MEDLINE | ID: mdl-29472118

RESUMO

OBJECTIVES: The odontogenic keratocyst (OKC) is an aggressive odontogenic cyst that has a high recurrence rate. Apart from PTCH1 mutations, few molecular alterations are described in OKCs. Low expression of microRNAs (miRNAs) miR-15a and/or miR-16-1 in association with increased expression of their target, Bcl-2, have been previously found in OKC. In humans, MIR15A and MIR16-1 are clustered at chromosome position 13 q14, and loss of heterozygosity (LOH) at this locus occurs in different tumors. We aimed to determine whether deletion at 13 q14 is a potential mechanism leading to miR-15a/16-1 aberrant expression in OKC. METHODS: Genomic DNA was extracted from 15 formalin-fixed, paraffin-embedded microdissected OKC cases. The polymorphic DNA markers D13S272 and D13S273 on chromosome 13 q14.3, around MIR15A/MIR16-1, were amplified by polymerase chain reaction. LOH was examined by capillary electrophoresis DNA-fragment analysis. RESULTS: The D13S272 marker had no LOH in 12 informative cases, whereas 2 out of 9 informative cases (22%) had LOH at the D13S273 marker. CONCLUSIONS: An LOH event at MIR15A/MIR16-1 locus is not common in OKC. The mechanism underlying the regulation of miR-15a and miR-16-1 expression in OKC remains to be determined.


Assuntos
Perda de Heterozigosidade , MicroRNAs/genética , Cistos Odontogênicos/genética , Tumores Odontogênicos/genética , Proteínas Proto-Oncogênicas c-bcl-2/genética , Adolescente , Adulto , Cromossomos Humanos Par 13 , Fragmentação do DNA , Eletroforese Capilar , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Cistos Odontogênicos/patologia , Tumores Odontogênicos/patologia , Reação em Cadeia da Polimerase
3.
Head Neck Pathol ; 2(4): 324-7, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20614303

RESUMO

Odontogenic tumors composed of two or more distinct types of lesions are unusual. In this paper, a case of an odontogenic lesion characterized by simultaneous occurrence of areas of calcifying odontogenic cyst (COC) and orthokeratinized odontogenic cyst (OOC) is described. The lesion was asymptomatic and presented at the radiographic examination as a unilocular well-delimited radiolucency extending from left incisor to right premolar area in the mandible. To date, this is the first report of COC associated with an OOC.


Assuntos
Neoplasias Maxilomandibulares/diagnóstico , Queratinas/metabolismo , Cisto Odontogênico Calcificante/diagnóstico , Biomarcadores Tumorais/metabolismo , Intervalo Livre de Doença , Feminino , Humanos , Neoplasias Maxilomandibulares/metabolismo , Neoplasias Maxilomandibulares/cirurgia , Cisto Odontogênico Calcificante/metabolismo , Cisto Odontogênico Calcificante/cirurgia , Resultado do Tratamento , Adulto Jovem
4.
Oral Oncol ; 43(3): 252-6, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16857408

RESUMO

Metallothionein (MT) is a protein that has been studied in several tumors as a prognostic factor and as a potential myoepithelial cell marker in breast cancer. The aims of this study were to assess the immunohistochemical staining of MT in adenoid cystic carcinomas of the salivary glands (ACC), and to analyze possible morphological and quantitative variations among the solid, cribriform, and tubular histological subtypes. MT was investigated in 15 cases of ACC using the immunohistochemical technique. All of the cases expressed the MT antigen. This expression was noteworthy in cells depicting myoepithelial differentiation. ACC with predominant tubular pattern presented a significantly lower mean index of MT immunopositivity than did solid or cribriform subtypes, while these two latter groups did not differ in terms of MT expression. Our results suggest that MT may be an important tool for immunolocalization of myoepithelial tumor cells in salivary gland neoplasms.


Assuntos
Carcinoma Adenoide Cístico/química , Metalotioneína/análise , Proteínas de Neoplasias/análise , Neoplasias das Glândulas Salivares/química , Adulto , Idoso , Carcinoma Adenoide Cístico/patologia , Transformação Celular Neoplásica/química , Transformação Celular Neoplásica/patologia , Feminino , Humanos , Imuno-Histoquímica/métodos , Masculino , Pessoa de Meia-Idade , Neoplasias das Glândulas Salivares/patologia , Glândulas Salivares/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...